<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(.) </span>
   <span class="font24">influenza </span>
   <span class="font20">FLU-v </span>
   <span class="font17">challenge </span>
   <span class="font17">study </span>
   <span class="font17">participants </span>
   <span class="font16">(%) </span>
   <span class="font15">vaccine </span>
   <span class="font14">vaccination </span>
   <span class="font14">adjuvanted </span>
   <span class="font14">group </span>
   <span class="font14">{border-style </span>
   <span class="font14">viral </span>
   <span class="font14">virus </span>
   <span class="font13">placebo </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">observed </span>
   <span class="font13">related </span>
   <span class="font13">symptoms </span>
   <span class="font13">challenge. </span>
   <span class="font13">human </span>
   <span class="font13">number </span>
   <span class="font13">shedding </span>
   <span class="font13">significant </span>
   <span class="font12">MMID </span>
   <span class="font12">efficacy </span>
   <span class="font12">cell </span>
   <span class="font12">cells </span>
   <span class="font12">data </span>
   <span class="font12">disease </span>
   <span class="font12">doses </span>
   <span class="font12">reduction </span>
   <span class="font12">response </span>
   <span class="font12">using </span>
   <span class="font12">AEs </span>
   <span class="font12">HAI </span>
   <span class="font12">considered </span>
   <span class="font12">dose </span>
   <span class="font12">total </span>
   <span class="font12">Influenza </span>
   <span class="font12">cytotoxic </span>
   <span class="font12">days </span>
   <span class="font12">demonstrated </span>
   <span class="font12">experienced </span>
   <span class="font12">immune </span>
   <span class="font12">phase </span>
   <span class="font12">protection </span>
   <span class="font12">received </span>
   <span class="font12">responses </span>
   <span class="font12">statistically </span>
   <span class="font11">Participants </span>
   <span class="font11">cellular </span>
   <span class="font11">clinical </span>
   <span class="font11">day </span>
   <span class="font11">groups </span>
   <span class="font11">primary </span>
   <span class="font11">severity </span>
   <span class="font11">test </span>
   <span class="font11">titers </span>
   <span class="font11">(−., </span>
   <span class="font11">compared </span>
   <span class="font11">healthy </span>
   <span class="font11">manuscript </span>
   <span class="font11">one-sided </span>
   <span class="font11">prior </span>
   <span class="font11">px; </span>
   <span class="font11">symptoms, </span>
   <span class="font11">two-dose </span>
   <span class="font11">{font-family </span>
   <span class="font11">(N = ) </span>
   <span class="font11">(Table </span>
   <span class="font11">Clinical </span>
   <span class="font11">Infectious </span>
   <span class="font11">National </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">immunity </span>
   <span class="font11">incidence </span>
   <span class="font11">individuals </span>
   <span class="font11">low </span>
   <span class="font11">mean </span>
   <span class="font11">population </span>
   <span class="font11">protective </span>
   <span class="font11">safety </span>
   <span class="font11">shedding, </span>
   <span class="font11">vaccines </span>
   <span class="font11">Allergy </span>
   <span class="font11">Exp. </span>
   <span class="font11">Intramural </span>
   <span class="font11">Research </span>
   <span class="font11">antibody </span>
   <span class="font11">available </span>
   <span class="font11">double; </span>
   <span class="font11">endpoint </span>
   <span class="font11">evaluated </span>
   <span class="font11">experiencing </span>
   <span class="font11">induce </span>
   <span class="font11">infection </span>
   <span class="font11">injection </span>
   <span class="font11">mild </span>
   <span class="font11">one-dose </span>
   <span class="font11">placebo, </span>
   <span class="font11">proteins </span>
   <span class="font11">provide </span>
   <span class="font11">shown </span>
   <span class="font11">studies </span>
   <span class="font11">(Fig. </span>
   <span class="font11">Diseases, </span>
   <span class="font11">FLU-v, </span>
   <span class="font11">IIb </span>
   <span class="font11">Institute </span>
   <span class="font11">Med../jem... </span>
   <span class="font11">NIAID </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">broadly </span>
   <span class="font11">design, </span>
   <span class="font11">developed </span>
   <span class="font11">duration </span>
   <span class="font11">effect </span>
   <span class="font11">evaluation </span>
   <span class="font11">influenza. </span>
   <span class="font11">intranasal </span>
   <span class="font11">peak </span>
   <span class="font11">protocol </span>
   <span class="font11">results </span>
   <span class="font11">significance </span>
   <span class="font11">solid; </span>
   <span class="font11">spectrum </span>
   <span class="font11">study. </span>
   <span class="font11">time </span>
   <span class="font11">titer </span>
   <span class="font11">trials </span>
   <span class="font11">virus. </span>
   <span class="font11">wild-type </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(HN)pdm </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">FLU-v. </span>
   <span class="font10">Fig. </span>
   <span class="font10">However, </span>
   <span class="font10">Montanide </span>
   <span class="font10">Phase </span>
   <span class="font10">Placebo </span>
   <span class="font10">Table </span>
   <span class="font10">[], </span>
   <span class="font10">addition, </span>
   <span class="font10">analysis </span>
   <span class="font10">analysis. </span>
   <span class="font10">antigen </span>
   <span class="font10">bold </span>
   <span class="font10">calculated </span>
   <span class="font10">confidence </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrate </span>
   <span class="font10">designed </span>
   <span class="font10">em; </span>
   <span class="font10">evaluate </span>
   <span class="font10">events </span>
   <span class="font10">included </span>
   <span class="font10">information </span>
   <span class="font10">likely </span>
   <span class="font10">lower </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">measured </span>
   <span class="font10">mice </span>
   <span class="font10">peptide </span>
   <span class="font10">previous </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">randomized, </span>
   <span class="font10">reduced </span>
   <span class="font10">research </span>
   <span class="font10">seasonal </span>
   <span class="font10">severity, </span>
   <span class="font10">single-dose </span>
   <span class="font10">site </span>
   <span class="font10">specific </span>
   <span class="font10">symptom </span>
   <span class="font10">trial </span>
   <span class="font10">used </span>
   <span class="font10">vaccine. </span>
  </p>
 </body>
</html>
